By vgreene, 11 September, 2015 If IIV used, should be given by clinician familiar w/ potential egg allergy manifestations, and recipients observed ≥30 min<sup>34</sup>
By vgreene, 11 September, 2015 Vaccinate all persons annually<sup>29</sup> w/ either trivalent recombinant influenza vaccine<sup>30,31</sup> (RIV3) (FluBlok) or IIV<sup>32,33</sup>
By vgreene, 11 September, 2015 Trivalent recombinant influenza vaccine (RIV3) not licensed for use in pts <18 yo
By vgreene, 11 September, 2015 Vaccinate all persons annually<sup>25</sup> w/ IIV;<sup>26,27</sup> vaccine should be given by clinician familiar w/ potential egg allergy manifestations, and recipients observed for ≥30 min<sup>28</sup>
By vgreene, 11 September, 2015 Vaccinate all persons annually<sup>21</sup> w/ IIV;<sup>22-24</sup> do not delay vaccination to procure a specific prep if another already available; LAIV contraindicated in pts >49 yo
By vgreene, 11 September, 2015 Vaccinate pregnant women annually<sup>17</sup> w/ IIV;<sup>18-20</sup> do not delay vaccination to procure a specific prep if another already available; LAIV contraindicated in pregnancy
By vgreene, 11 September, 2015 Vaccinate all persons annually<sup>11</sup> w/ IIV<sup>12,13</sup> or LAIV;<sup>14-16</sup> do not delay vaccination to procure a specific prep if another already available
By vgreene, 11 September, 2015 Has child received ≥2 total doses of trivalent/quadrivalent influenza vaccine before July 1, 2015?